{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:37:13Z","timestamp":1788482233480,"version":"build-2803163510"},"reference-count":165,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>With global population aging, senescence has emerged as a key driver of tumorigenesis. Aging-associated molecular changes, including DNA damage, telomere shortening, and epigenetic dysregulation, increase malignancy, while immunosenescence and the senescence-associated secretory phenotype (SASP), reshape the tumor microenvironment to favor immune suppression and tumor escape. Aging also impairs antigen presentation, disrupts ligand-receptor signaling, and compromises tumor suppressive pathways. In the era of immunotherapy, elderly patients face reduced efficacy and increased resistance due to age-related immune remodeling. This review summarizes mechanisms of tumor immune escape in aging and discusses strategies to improve outcomes, such as senescent cell clearance, SASP modulation, immune potentiation, and combination therapies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1785351","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:41:56Z","timestamp":1773124916000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Conquering aging-related immunosenescence and tumor immune escape"],"prefix":"10.3389","volume":"17","author":[{"given":"Shanshan","family":"Zhang","sequence":"first","affiliation":[{"name":"Shandong Provincial Key Medical and Health Laboratory of Blood Ecology and Biointelligence, Science and Technology Innovation Center, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]},{"name":"Jinan Key Laboratory of Medical Cell Bioengineering, Science and Technology Innovation Center, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Fourth Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Xu","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Medical and Health Laboratory of Blood Ecology and Biointelligence, Science and Technology Innovation Center, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]},{"name":"Jinan Key Laboratory of Medical Cell Bioengineering, Science and Technology Innovation Center, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]},{"name":"College of Life Science and Technology & College of Basic Medicine, Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Bing","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Medical and Health Laboratory of Blood Ecology and Biointelligence, Science and Technology Innovation Center, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]},{"name":"Jinan Key Laboratory of Medical Cell Bioengineering, Science and Technology Innovation Center, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]},{"name":"College of Life Science and Technology & College of Basic Medicine, Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University","place":["Quanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Medical and Health Laboratory of Blood Ecology and Biointelligence, Science and Technology Innovation Center, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]},{"name":"Jinan Key Laboratory of Medical Cell Bioengineering, Science and Technology Innovation Center, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University","place":["Quanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leisheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Medical and Health Laboratory of Blood Ecology and Biointelligence, Science and Technology Innovation Center, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]},{"name":"Jinan Key Laboratory of Medical Cell Bioengineering, Science and Technology Innovation Center, The Fourth People\u2019s Hospital of Jinan Affiliated to Shandong Second Medical University","place":["Jinan, China"]},{"name":"College of Life Science and Technology & College of Basic Medicine, Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afad043","article-title":"The occurence of cancer in ageing populations at global and regional levels, 1990 to 2019","volume":"52","author":"Ju","year":"2023","journal-title":"Age Ageing"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.2198.356","article-title":"A contribution TO THE STUDY OF CANCER MORTALITY: an address delivered to the dundee and district branch of the british medical association","volume":"1","author":"Templeman","year":"1903","journal-title":"Br Med J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.4032.829","article-title":"On the origin of cancer","volume":"1","author":"Cramer","year":"1938","journal-title":"Br Med J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj7050","article-title":"Cellular senescence in normal physiology","volume":"384","author":"De Magalh\u00e3es","year":"2024","journal-title":"Sci (N Y NY)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102616","article-title":"Hallmarks of aging: A user\u2019s guide for comparative biologists","volume":"104","author":"Biga","year":"2025","journal-title":"Ageing Res Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12102052","article-title":"Immunosenescence: how aging increases susceptibility to bacterial infections and virulence factors","volume":"12","author":"Theodorakis","year":"2024","journal-title":"Microorganisms"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01748","article-title":"Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response","volume":"11","author":"Cunha","year":"2020","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121314","article-title":"Immunosenescence: aging and immune system decline","volume":"12","author":"Goyani","year":"2024","journal-title":"Vaccines"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1708280","article-title":"Immunosenescence and inflammaging: mechanisms and modulation through diet and lifestyle","volume":"16","author":"M\u00fcller","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transd Targ Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00905-1","article-title":"Inflammation and DNA damage: cause, effect or both","volume":"19","author":"Pezone","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e62852","DOI":"10.7554\/eLife.62852","article-title":"DNA damage-how and why we age","volume":"10","author":"Yousefzadeh","year":"2021","journal-title":"Elife"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00026.2007","article-title":"Telomeres and aging","volume":"88","author":"Aubert","year":"2008","journal-title":"Physiol Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"eaaw3835","DOI":"10.1126\/science.aaw3835","article-title":"Epigenetics as a mediator of plasticity in cancer","volume":"379","author":"Feinberg","year":"2023","journal-title":"Sci (N Y NY)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e695","DOI":"10.1002\/mco2.695","article-title":"The dual role of cellular senescence in human tumor progression and therapy","volume":"5","author":"Ma","year":"2024","journal-title":"Medcomm"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00727-x","article-title":"The senescence-associated secretory phenotype and its physiological and pathological implications","volume":"25","author":"Wang","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11762","article-title":"Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis","volume":"7","author":"Ruhland","year":"2016","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Copp\u00e9","year":"2008","journal-title":"PloS Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41586-025-09686-5","article-title":"Multi-omic profiling reveals age-related immune dynamics in healthy adults","volume":"648","author":"Gong","year":"2025","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e70032","DOI":"10.1111\/acel.70032","article-title":"A single-cell transcriptome atlas characterizes the immune landscape of human testes during aging","volume":"24","author":"Jiang","year":"2025","journal-title":"Aging Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2025.1596050","article-title":"Advances in the application of multi-omics analysis in skin aging","volume":"6","author":"Long","year":"2025","journal-title":"Front Aging"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-025-00819-z","article-title":"Single-cell immune aging clocks reveal inter-individual heterogeneity during infection and vaccination","volume":"5","author":"Li","year":"2025","journal-title":"Nat Aging"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/195956","article-title":"NK cells in healthy aging and age-associated diseases","volume":"2012","author":"Camous","year":"2012","journal-title":"J BioMed Biotechnol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.0105-2896.2005.00260.x","article-title":"Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes","volume":"205","author":"Stout","year":"2005","journal-title":"Immunol Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","article-title":"Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transd Targ Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41577-021-00557-4","article-title":"The role of T cells in age-related diseases","volume":"22","author":"Carrasco","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2016.10.001","article-title":"SASP: tumor suppressor or promoter? Yes","volume":"2","author":"Rao","year":"2016","journal-title":"Trends Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.ccell.2023.05.004","article-title":"Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer","volume":"41","author":"Haston","year":"2023","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1510079","article-title":"Releasing the brakes on cancer immunotherapy","volume":"373","author":"Ribas","year":"2015","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698565","article-title":"p16INK4a regulates cellular senescence in PD-1-expressing human T cells","volume":"12","author":"Janelle","year":"2021","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01726-1","article-title":"PSMA-targeting TGF\u03b2-insensitive armored CAR T\u2009cells in metastatic castration-resistant prostate cancer: a phase 1 trial","volume":"28","author":"Narayan","year":"2022","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1189\u20131198","DOI":"10.1038\/s41591-022-01800-8","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results","volume":"28","author":"C","year":"2022","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32409-7","article-title":"Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial","volume":"393","author":"Mok","year":"2019","journal-title":"Lancet (lond Engl)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet (lond Engl)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1038\/s41467-024-46769-9","article-title":"Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment","volume":"15","author":"Maggiorani","year":"2024","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0697-6","article-title":"Does patient age influence anti-cancer immunity","volume":"41","author":"Pawelec","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/4.4.195","article-title":"The immunologic theory of aging","volume":"4","author":"Walford","year":"1964","journal-title":"Gerontologist"},{"key":"B43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-017-0006-x","article-title":"The twilight of immunity: emerging concepts in aging of the immune system","volume":"19","author":"Nikolich-\u017dugich","year":"2018","journal-title":"Nat Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41392-025-02371-z","article-title":"Immunosenescence: signaling pathways, diseases and therapeutic targets","volume":"10","author":"Fu","year":"2025","journal-title":"Signal Transd Targ Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"106413","DOI":"10.1016\/j.ejim.2025.07.009","article-title":"Senolytic therapies for cardiovascular aging: tackling fibrosis and metabolic dysfunction","volume":"140","author":"Atlante","year":"2025","journal-title":"Eur J Intern Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40035-025-00517-1","article-title":"Immunosenescence in aging and neurodegenerative diseases: evidence, key hallmarks, and therapeutic implications","volume":"14","author":"Chen","year":"2025","journal-title":"Transl Neurodegener"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2024.102498","article-title":"The immunometabolic roots of aging","volume":"91","author":"Ginefra","year":"2024","journal-title":"Curr Opin Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2024.0140","article-title":"T-cell senescence in human metabolic diseases","volume":"48","author":"Nga","year":"2024","journal-title":"Diabetes Metab J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112900","article-title":"Immunosenescence: a new direction in anti-aging research","volume":"141","author":"Li","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e2023216118","DOI":"10.1073\/pnas.2023216118","article-title":"Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis","volume":"118","author":"Huang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/25374","article-title":"Changes in thymic function with age and during the treatment of HIV infection","volume":"396","author":"Douek","year":"1998","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.02111","article-title":"Mechanisms underlying T cell immunosenescence: aging and cytomegalovirus infection","volume":"7","author":"Tu","year":"2016","journal-title":"Front Microbiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00733","article-title":"Latent cytomegalovirus (CMV) infection does not detrimentally alter T cell responses in the healthy old, but increased latent CMV carriage is related to expanded CMV-specific T cells","volume":"8","author":"Jackson","year":"2017","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12059","article-title":"Medical research council cognitive function and ageing study","volume":"12","author":"Savva","year":"2013","journal-title":"Aging Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.stem.2022.04.017","article-title":"Heterochronic parabiosis induces stem cell revitalization and systemic rejuvenation across aged tissues","volume":"29","author":"Ma","year":"2022","journal-title":"Cell Stem Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1116110108","article-title":"Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age","volume":"108","author":"Pang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-023-00403-2","article-title":"An aging-related immune landscape in the hematopoietic immune system","volume":"21","author":"Lv","year":"2024","journal-title":"Immun Ageing: A"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-092419-031130","article-title":"Age-associated B cells","volume":"38","author":"Cancro","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-457929","article-title":"CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age","volume":"121","author":"Gekas","year":"2013","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e2412317122","DOI":"10.1073\/pnas.2412317122","article-title":"Periarteriolar niches become inflamed in aging bone marrow, remodeling the stromal microenvironment and depleting lymphoid progenitors","volume":"122","author":"Du","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2025.104749","article-title":"Bone marrow niches for hematopoietic stem cells in homeostasis and aging","volume":"144","author":"Nakatani","year":"2025","journal-title":"Exp Hematol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12979-024-00452-1","article-title":"Deciphering the impact of aging on splenic endothelial cell heterogeneity and immunosenescence through single-cell RNA sequencing analysis","volume":"21","author":"Huang","year":"2024","journal-title":"Immun Ageing: A"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113148","article-title":"Aging-related cellular, structural and functional changes in the lymph nodes: a significant component of immunosenescence? An overview","volume":"10","author":"Cakala-Jakimowicz","year":"2021","journal-title":"Cells"},{"key":"B65","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/imm.12590","article-title":"Disorganization of the splenic microanatomy in ageing mice","volume":"148","author":"Aw","year":"2016","journal-title":"Immunology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/acel.12435","article-title":"Characterization of age-associated exhausted CD8+ T cells defined by increased expression of tim-3 and PD-1","volume":"15","author":"Lee","year":"2016","journal-title":"Aging Cell"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137016","article-title":"Immune aging and immunotherapy in cancer","volume":"22","author":"Kaiser","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1596686","article-title":"Immune cell senescence in autoimmunity: implications for disease pathogenesis and therapeutic targeting","volume":"16","author":"Yin","year":"2025","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2022.11.005","article-title":"Age-associated remodeling of T cell immunity and metabolism","volume":"35","author":"Han","year":"2023","journal-title":"Cell Metab"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00927-z","article-title":"Hallmarks of T cell aging","volume":"22","author":"Mittelbrunn","year":"2021","journal-title":"Nat Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101818","article-title":"T cell control of inflammaging","volume":"70","author":"Shchukina","year":"2023","journal-title":"Semin Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"eadv7615","DOI":"10.1126\/sciimmunol.adv7615","article-title":"cells drive CD4 T cell immunosenescence and age-associated health decline","volume":"11","author":"Khan","year":"2026","journal-title":"Sci Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.733566","article-title":"The dynamics of B cell aging in health and disease","volume":"12","author":"de Mol","year":"2021","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118000","article-title":"Rosuvastatin restores liver tissue-resident NK cell activation in aged mice by improving mitochondrial function","volume":"186","author":"Amer","year":"2025","journal-title":"BioMed Pharmacother = BioMed Pharmacother"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111715","article-title":"Immune signature and phagocytosis of circulating DC subsets in healthy adults during aging","volume":"130","author":"Cui","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging: an evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/692546","article-title":"The impact of immunosenescence on pulmonary disease","volume":"2015","author":"Murray","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B78","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","article-title":"How the ageing microenvironment influences tumour progression","volume":"20","author":"Fane","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.05.004","article-title":"Senescent cells in cancer therapy: friends or foes","volume":"6","author":"Wang","year":"2020","journal-title":"Trends Cancer"},{"key":"B80","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Copp\u00e9","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/cells14080608","article-title":"SASP modulation for cellular rejuvenation and tissue homeostasis: therapeutic strategies and molecular insights","volume":"14","author":"Alqahtani","year":"2025","journal-title":"Cells"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e3000599","DOI":"10.1371\/journal.pbio.3000599","article-title":"A proteomic atlas of senescence-associated secretomes for aging biomarker development","volume":"18","author":"Basisty","year":"2020","journal-title":"PloS Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102065","article-title":"Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders","volume":"91","author":"De Oliveira Silva","year":"2025","journal-title":"Mol Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0523","article-title":"Cellular senescence is immunogenic and promotes antitumor immunity","volume":"13","author":"Marin","year":"2023","journal-title":"Cancer Discov"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2024.06.007","article-title":"Immune surveillance of senescence: potential application to age-related diseases","volume":"35","author":"Wang","year":"2025","journal-title":"Trends Cell Biol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12979-025-00518-8","article-title":"Targeting immunosenesence promotes clearance of senescent cells","volume":"22","author":"Tizazu","year":"2025","journal-title":"Immun Ageing: A"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130783","article-title":"p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells","volume":"210","author":"Iannello","year":"2013","journal-title":"J Exp Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e202010162","DOI":"10.1083\/jcb.202010162","article-title":"Similarities and interplay between senescent cells and macrophages","volume":"220","author":"Behmoaras","year":"2021","journal-title":"J Cell Biol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.0720","article-title":"Advancements in targeting macrophage senescence for age-associated conditions","volume":"16","author":"Xiao","year":"2024","journal-title":"Aging Dis"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0118","article-title":"Combined blockade of IL6 and PD-1\/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment","volume":"78","author":"Tsukamoto","year":"2018","journal-title":"Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1101\/gad.17276711","article-title":"Control of the senescence-associated secretory phenotype by NF-\u03baB promotes senescence and enhances chemosensitivity","volume":"25","author":"Chien","year":"2011","journal-title":"Genes Dev"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1605085","article-title":"Senescence-associated secretory phenotype in lung cancer: remodeling the tumor microenvironment for metastasis and immune suppression","volume":"15","author":"Chen","year":"2025","journal-title":"Front Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.09.003","article-title":"Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor progression","volume":"30","author":"Eggert","year":"2016","journal-title":"Cancer Cell"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00712-x","article-title":"The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2","volume":"5","author":"Chaib","year":"2024","journal-title":"Nat Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1375730","article-title":"Impact and potential value of immunosenescence on solid gastrointestinal tumors","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222112015","article-title":"Reconstituting immune surveillance in breast cancer: molecular pathophysiology and current immunotherapy strategies","volume":"22","author":"Cilibrasi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.12.010","article-title":"Small-molecule agents for cancer immunotherapy","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B98","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.arr.2008.07.002","article-title":"Molecular inflammation: underpinnings of aging and age-related diseases","volume":"8","author":"Chung","year":"2009","journal-title":"Ageing Res Rev"},{"key":"B99","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838660","article-title":"Synergistic up-regulation of MCP-2\/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects","volume":"39","author":"Struyf","year":"2009","journal-title":"Eur J Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1038\/s41467-019-10335-5","article-title":"Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition","volume":"10","author":"Pereira","year":"2019","journal-title":"Nat Commun"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888313","article-title":"Plasticity of NK cells in cancer","volume":"13","author":"Corvino","year":"2022","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101073","article-title":"Advances in NK cell therapy for hematologic Malignancies: NK source, persistence and tumor targeting","volume":"60","author":"Merino","year":"2023","journal-title":"Blood Rev"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e1230","DOI":"10.1002\/cti2.1230","article-title":"NKG2D and MICA\/B shedding: a \u201ctag game\u201d between NK cells and Malignant cells","volume":"9","author":"Xing","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060915","article-title":"Emerging therapeutic approaches to target the dark side of senescent cells: new hopes to treat aging as a disease and to delay age-related pathologies","volume":"12","author":"Khalil","year":"2023","journal-title":"Cells"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2007.02652.x","article-title":"Regulation of ligands for the activating receptor NKG2D","volume":"121","author":"Mistry","year":"2007","journal-title":"Immunology"},{"key":"B110","article-title":"Role of NKG2D and its ligands in cancer immunotherapy","volume":"9","author":"Liu","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28174","article-title":"Shedding of endogenous MHC class I-related chain molecules a and B from different human tumor entities: heterogeneous involvement of the \u201ca disintegrin and metalloproteases\u201d 10 and 17","volume":"133","author":"Chitadze","year":"2013","journal-title":"Int J Cancer"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00476","article-title":"NKG2D and its ligands: \u201cone for all, all for one","volume":"9","author":"Zingoni","year":"2018","journal-title":"Front Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01465-0","article-title":"p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells","volume":"26","author":"Majewska","year":"2024","journal-title":"Nat Cell Biol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0017122","DOI":"10.1128\/mcb.00171-22","article-title":"Upregulation of PD-L1 in senescence and aging","volume":"42","author":"Onorati","year":"2022","journal-title":"Mol Cell Biol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-022-01328-x","article-title":"Targeting macrophages in hematological Malignancies: recent advances and future directions","volume":"15","author":"Li","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101280","article-title":"Feed-forward regulation between cellular senescence and immunosuppression promotes the aging process and age-related diseases","volume":"67","author":"Salminen","year":"2021","journal-title":"Ageing Res Rev"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-012-9440-8","article-title":"MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling","volume":"35","author":"Olivieri","year":"2013","journal-title":"Age (dordr Neth)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101823","article-title":"miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J Exp Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-102419-035900","article-title":"Siglecs as immune cell checkpoints in disease","volume":"38","author":"Duan","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"key":"B123","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-025-02284-z","article-title":"Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways","volume":"24","author":"Liu","year":"2025","journal-title":"Mol Cancer"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25777","article-title":"Tim-3\/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma","volume":"56","author":"Li","year":"2012","journal-title":"Hepatol (Baltim Md)"},{"key":"B125","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13045-023-01426-4","article-title":"Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications","volume":"16","author":"Zhao","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199687","article-title":"Heterogeneity of cellular senescence, senotyping, and targeting by senolytics and senomorphics in lung diseases","volume":"26","author":"Ozdemir","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B127","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2741\/4889","article-title":"Signaling pathways and effectors of aging","volume":"26","author":"Tabibzadeh","year":"2021","journal-title":"Front Biosci (Landm Ed)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.7.5657","article-title":"The tumor suppressor p53: cancer and aging","volume":"7","author":"Feng","year":"2008","journal-title":"Cell Cycle (Georget Tex)"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.614","article-title":"p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors","volume":"30","author":"Romagosa","year":"2011","journal-title":"Oncogene"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-022-00250-8","article-title":"Characterization of cellular senescence in aging skeletal muscle","volume":"2","author":"Zhang","year":"2022","journal-title":"Nat Aging"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.840827","article-title":"Inflammation, immune senescence, and dysregulated immune regulation in the elderly","volume":"3","author":"Shive","year":"2022","journal-title":"Front Aging"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e1002594","DOI":"10.1371\/journal.ppat.1002594","article-title":"TGF-\u03b21 down-regulation of NKG2D\/DAP10 and 2B4\/SAP expression on human NK cells contributes to HBV persistence","volume":"8","author":"Sun","year":"2012","journal-title":"PloS Pathog"},{"key":"B133","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/neuonc\/nop009","article-title":"TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients","volume":"12","author":"Crane","year":"2010","journal-title":"Neuro-oncol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S435001","article-title":"Immunotherapy in older patients with cancer: a narrative review","volume":"17","author":"Smith","year":"2024","journal-title":"Int J Gen Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: the path to the clinic","volume":"28","author":"Chaib","year":"2022","journal-title":"Nat Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16350","article-title":"Targeting cellular senescence with senotherapeutics: senolytics and senomorphics","volume":"290","author":"Zhang","year":"2023","journal-title":"FEBS J"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112685","article-title":"Exercise and exerkines: mechanisms and roles in anti-aging and disease prevention","volume":"200","author":"Lu","year":"2025","journal-title":"Exp Gerontol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2023.1228756","article-title":"Editorial: inflammation, aging, and disease: new perspectives and interventions","volume":"4","author":"Duggal","year":"2023","journal-title":"Front Aging"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e13767","DOI":"10.1111\/acel.13767","article-title":"Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age","volume":"22","author":"Islam","year":"2023","journal-title":"Aging Cell"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27082498","article-title":"Health benefits of quercetin in age-related diseases","volume":"27","author":"Deepika","year":"2022","journal-title":"Mol (Basel Switz)"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05388-4","article-title":"Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes","volume":"611","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0241","article-title":"Cellular senescence promotes adverse effects of chemotherapy and cancer relapse","volume":"7","author":"Demaria","year":"2017","journal-title":"Cancer Discov"},{"key":"B145","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12943-025-02459-8","article-title":"Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy","volume":"24","author":"Yang","year":"2025","journal-title":"Mol Cancer"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1101\/gad.353134.125","article-title":"Killing wisely: precision senolytics in the age of frailty","volume":"39","author":"Barthet","year":"2025","journal-title":"Genes Dev"},{"key":"B147","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","article-title":"Benefits of metformin in attenuating the hallmarks of aging","volume":"32","author":"Kulkarni","year":"2020","journal-title":"Cell Metab"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(23)00258-1","article-title":"Targeting ageing with rapamycin and its derivatives in humans: a systematic review","volume":"5","author":"Lee","year":"2024","journal-title":"Lancet Healt Longev"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3225","article-title":"mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype","volume":"17","author":"Herranz","year":"2015","journal-title":"Nat Cell Biol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age","volume":"112","author":"Xu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B151","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41368-025-00380-w","article-title":"Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy","volume":"17","author":"Luo","year":"2025","journal-title":"Int J Oral Sci"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00597-0","article-title":"Targeting aging and age-related diseases with vaccines","volume":"4","author":"Wu","year":"2024","journal-title":"Nat Aging"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46436","article-title":"Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics","volume":"11","author":"Zhu","year":"2021","journal-title":"Theranostics"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-024-01528-3","article-title":"Immune checkpoint inhibitors in geriatric oncology","volume":"26","author":"Cook","year":"2024","journal-title":"Curr Oncol Rep"},{"key":"B155","doi-asserted-by":"publisher","first-page":"101840","DOI":"10.1016\/j.smim.2023.101840","article-title":"Beyond youth: understanding CAR T cell fitness in the context of immunological aging","volume":"70","author":"Jh","year":"2023","journal-title":"Semin Immunol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transd Targ Ther"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.02.006","article-title":"Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: a systematic review and meta-analysis","volume":"45","author":"Nishijima","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"B158","doi-asserted-by":"publisher","first-page":"e011648","DOI":"10.1136\/jitc-2025-011648","article-title":"FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma","volume":"13","author":"Xu","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216038","article-title":"Immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"555","author":"Wang","year":"2023","journal-title":"Cancer Lett"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.100948","article-title":"Immunosenescence, physical exercise, and their implications in tumor immunity and immunotherapy","volume":"21","author":"Yu","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1604310","article-title":"T lymphocyte heterogeneity in NSCLC: implications for biomarker development and therapeutic innovation","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"e20634","DOI":"10.1002\/advs.202520634","article-title":"T cell exhaustion in cancer immunotherapy: heterogeneity, mechanisms, and therapeutic opportunities","author":"Yu","year":"2026","journal-title":"Adv Sci"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02247","article-title":"Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention","volume":"10","author":"Aiello","year":"2019","journal-title":"Front Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100878","article-title":"CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy","volume":"4","author":"Huseni","year":"2023","journal-title":"Cell Rep Med"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01238-7","article-title":"The antitumor activity of TGF\u03b2-specific T cells is dependent on IL-6 signaling","volume":"22","author":"Perez-Penco","year":"2025","journal-title":"Cell Mol Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1785351\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:41:58Z","timestamp":1773124918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1785351\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":165,"alternative-id":["10.3389\/fimmu.2026.1785351"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1785351","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"article-number":"1785351"}}